We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
-0.42%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$388M
AUM Growth
-$58.9M
Cap. Flow
-$52M
Cap. Flow %
-13.41%
Top 10 Hldgs %
66.6%
Holding
38
New
1
Increased
13
Reduced
15
Closed
7

Top Buys

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$10.2M
2
ELV icon
Elevance Health
ELV
+$5.61M
3
SGEN
Seagen Inc. Common Stock
SGEN
+$5.53M
4
BIIB icon
Biogen
BIIB
+$3.77M
5
ZBH icon
Zimmer Biomet
ZBH
+$3.33M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$14.4M
2
CVS icon
CVS Health
CVS
+$12.3M
3
OGN icon
Organon & Co
OGN
+$12M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$9.43M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$6.85M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RARE icon
26
Ultragenyx Pharmaceutical
RARE
$2.65B
$1.89M 0.49%
45,520
-701
-2% -$36K
VIR icon
27
Vir Biotechnology
VIR
$1.47B
$1.73M 0.45%
89,808
-20,415
-19% -$519K
RIGL icon
28
Rigel Pharmaceuticals
RIGL
$680M
$1.59M 0.41%
134,690
-11,978
-8% -$162K
ALNY icon
29
Alnylam Pharmaceuticals
ALNY
$36.3B
$1.39M 0.36%
6,921
-35,923
-84% -$6.85M
NVAX icon
30
Novavax
NVAX
$1.23B
$1.03M 0.27%
56,735
+1,411
+3% +$61.1K
EMBC icon
31
Embecta
EMBC
$195M
$151K 0.04%
5,246
– –
ABT icon
32
Abbott
ABT
$180B
– –
-49,205
Closed -$5.35M
ATRA icon
33
Atara Biotherapeutics
ATRA
$71.2M
– –
-4,949
Closed -$964K
OGN icon
34
Organon & Co
OGN
$3.55B
– –
-356,089
Closed -$12M
PFE icon
35
Pfizer
PFE
$140B
– –
-100,000
Closed -$5.24M
QTRX icon
36
Quanterix
QTRX
$173M
– –
-88,670
Closed -$1.44M
VRTX icon
37
Vertex Pharmaceuticals
VRTX
$121B
– –
-33,474
Closed -$9.43M
SLGC
38
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
– –
-301,224
Closed -$1.36M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q3 2022 Portfolio in Review

As of Q3 2022, Sector Gamma AS held 38 positions worth $388M, down 13% from $447M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Sector Gamma AS withdrew a net $52M in Q3 2022, closing 7 positions and reducing 15 holdings. Its most notable exit was Organon & Co, an estimated $12M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Sector Gamma AS opened a new position in Baxter International worth $9.1M.

  • Sector Gamma AS's largest Q3 2022 buy was Baxter International: 169,028 shares worth $9.1M.
  • Sector Gamma AS added most to Elevance Health in Q3 2022, an estimated $5.61M increase.
  • Sector Gamma AS's biggest Q3 2022 reduction was Merck, cutting an estimated $14.4M.
  • Sector Gamma AS fully exited Organon & Co in Q3 2022, selling an estimated $12M.
  • Sector Gamma AS's ten largest holdings make up 67% of its $388M portfolio in Q3 2022.
  • Sector Gamma AS opened 1 new position and closed 7 in Q3 2022.
  • Sector Gamma AS's portfolio value fell 13% quarter-over-quarter to $388M.

Based on Sector Gamma AS's 13F filing for Q3 2022, filed 9 Nov 2022.